...
首页> 外文期刊>Clinical chemistry and laboratory medicine: CCLM >Experience with external quality assessment of drugs of abuse testing in the Lombardy Region in Italy.
【24h】

Experience with external quality assessment of drugs of abuse testing in the Lombardy Region in Italy.

机译:在意大利伦巴第大区进行滥用药物测试的外部质量评估经验。

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Following up previous experience with External Quality Assessment (EQA) and Proficiency Testing Programs (PTP) on drugs of abuse (DoA) testing in Italy and in other European countries, the government of the Lombardy Region, first among Italian regions, established in 1995 a compulsory EQA scheme for laboratories authorized to perform these tests. The purpose of the present work is the description of the program and the overall evaluation of the results obtained in the first three annual cycles (1995-1998). During each annual cycle laboratories received 22 urine samples; some samples were collected from patients ("real samples") and some were "spiked" urine samples. Both types of samples could contain the following substances/classes of substances: opiates, cocaine, cannabinoids, methadone, buprenorphine, benzodiazepines, barbiturates. Type A laboratories used an immunological screening method; they expressed the results as concentrations. Type B laboratories, authorized to perform screening methods followed by confirmatory techniques, searched for and identified single substances and provided an interpretation on possibly taken drugs. During the study period the laboratories produced about 21,000 analytical results. Among them, false-negative results were 0.9% of true positives, and false-positive results were 0.7% of true negatives. Performance using the spiked samples was better than using real samples, and performance of type B laboratories better than that of type A. The results obtained during the program are consistent with those of other quality control programs. This program, in addition, has provided information on the status of DoA testing in the Lombardy region's laboratories, in particular on their analytical performance, on the quality of interpretation of results and on a degree of improvement achieved during the program.
机译:继意大利和其他欧洲国家在滥用药物(DoA)测试方面进行外部质量评估(EQA)和能力验证计划(PTP)的经验之后,伦巴第大区政府于1995年成立,这在意大利地区中是首位。授权进行这些测试的实验室的强制性EQA计划。本工作的目的是对计划进行描述,并对前三个年度周期(1995-1998年)获得的结果进行总体评估。在每个年度周期中,实验室共收到22份尿液样本。一些样本是从患者那里收集的(“真实样本”),有些是“加标”的尿液样本。两种类型的样品都可能包含以下物质/物质类别:阿片剂,可卡因,大麻素,美沙酮,丁丙诺啡,苯二氮卓,巴比妥酸盐。 A型实验室采用了免疫学筛查方法;他们将结果表示为浓度。 B类实验室有权执行筛查方法,然后再采用确认性技术,以搜寻和识别单一物质,并对可能服用的药物提供解释。在研究期间,实验室产生了约21,000个分析结果。其中,假阴性结果为真阳性的0.9%,假阳性结果为真阴性的0.7%。使用加标样品的性能要优于使用真实样品的性能,B型实验室的性能要优于A型实验室。该程序期间获得的结果与其他质量控制程序的结果一致。此外,该计划还提供了有关伦巴第地区实验室中DoA测试状态的信息,尤其是其分析性能,结果解释的质量以及在该计划中取得的改进程度。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号